N Ariela Arad

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Decreased absolute lymphocyte counts (ALCs) following frontline therapy for chronic lymphocytic leukemia may be associated with disease control, even in patients without evidence of minimal residual disease. We studied the prognostic significance of ALCs during the first year following treatment with fludarabine, cyclophosphamide, and rituximab (FCR). We(More)
  • 1